CORRADINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 8.057
EU - Europa 4.470
AS - Asia 3.670
SA - Sud America 589
AF - Africa 54
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.855
Nazione #
US - Stati Uniti d'America 7.969
IT - Italia 1.351
CN - Cina 1.312
GB - Regno Unito 1.258
SG - Singapore 1.045
BR - Brasile 484
SE - Svezia 465
HK - Hong Kong 463
DE - Germania 339
VN - Vietnam 248
RU - Federazione Russa 191
KR - Corea 179
UA - Ucraina 173
FI - Finlandia 148
FR - Francia 136
TR - Turchia 122
NL - Olanda 101
ID - Indonesia 73
BG - Bulgaria 62
CA - Canada 54
AR - Argentina 51
IN - India 50
LT - Lituania 36
IE - Irlanda 35
BD - Bangladesh 29
JP - Giappone 29
AT - Austria 28
BE - Belgio 28
PL - Polonia 24
RO - Romania 24
MX - Messico 23
ZA - Sudafrica 18
IQ - Iraq 16
CH - Svizzera 15
MY - Malesia 15
EC - Ecuador 14
PK - Pakistan 12
ES - Italia 11
CO - Colombia 10
MA - Marocco 10
AU - Australia 9
IL - Israele 9
EG - Egitto 8
IR - Iran 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
PT - Portogallo 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
PY - Paraguay 6
KZ - Kazakistan 5
LU - Lussemburgo 5
PE - Perù 5
TW - Taiwan 5
AL - Albania 4
GR - Grecia 4
HU - Ungheria 4
KE - Kenya 4
NP - Nepal 4
PH - Filippine 4
SA - Arabia Saudita 4
BY - Bielorussia 3
OM - Oman 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
Totale 16.849
Città #
Santa Clara 992
Fairfield 869
Southend 821
Ashburn 699
Singapore 673
Hefei 543
Woodbridge 489
Chandler 485
Hong Kong 462
Houston 407
London 309
Seattle 287
Cambridge 277
Jacksonville 257
Nyköping 255
Wilmington 254
Dallas 235
Ann Arbor 209
Dearborn 208
Modena 199
Beijing 190
Seoul 165
Chicago 146
Los Angeles 131
San Diego 100
New York 90
Milan 85
Bologna 83
Helsinki 83
Ho Chi Minh City 83
Princeton 69
Council Bluffs 64
The Dalles 62
Munich 61
Sofia 61
Moscow 60
Hanoi 59
Izmir 54
Jakarta 52
Eugene 49
Shanghai 49
São Paulo 48
Parma 47
Rome 46
Redwood City 43
Buffalo 39
Salt Lake City 37
Bremen 36
Yalova 33
Dublin 27
Reggio Emilia 26
Amsterdam 25
Elk Grove Village 24
Nuremberg 24
Phoenix 24
Redondo Beach 24
Brussels 23
Des Moines 23
Kent 23
Stockholm 23
Frankfurt am Main 22
Florence 21
Tokyo 20
Brooklyn 19
Borzano 18
Bari 17
Turku 17
Warsaw 17
Formigine 16
Hemrik 16
Rimini 16
Rio de Janeiro 16
Tampa 16
Toronto 15
Columbus 14
Dong Ket 14
Guangzhou 14
Vienna 14
Lappeenranta 13
Sterling 13
Haiphong 12
Kassel 12
Kilburn 12
Norwalk 12
Padova 12
Paris 12
Trento 12
Chennai 11
Montreal 11
Orem 11
Ottawa 11
Reggio Nell'emilia 11
Timisoara 11
Atlanta 10
Boardman 10
Frattamaggiore 10
Mexico City 10
Quartu Sant'Elena 10
San Francisco 10
Verona 10
Totale 11.869
Nome #
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 379
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 358
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 350
Non-HFE Hepatic Iron Overload. 340
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 321
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 319
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 307
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 296
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 288
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 287
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 283
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 279
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 278
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 276
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 275
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 274
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 272
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 271
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 269
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 265
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 265
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 261
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 258
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 258
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 245
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 238
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 237
Disease progression and liver cancer in the ferroportin disease 229
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 226
Lack of enterocyte iron accumulation in the ferroportin disease 225
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 223
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 222
Iron and steatohepatitis. 219
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 218
Fifty meanings of grey 217
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 216
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 216
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 212
The RGM/DRAGON family of BMP co-receptors. 210
Hereditary hemochromatosis. 205
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 203
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 193
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 192
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 191
Hereditary Hemochromatosis 189
null 186
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 178
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 172
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 170
Hereditary Haemochromatosis: the genes and the disease. 168
Impact of natural neuromedin-B receptor variants on iron metabolism 166
Fortune favours the bold: finding the right route in the anemia's sea 163
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 159
Hyperferritinemia and diagnosis of type 1 Gaucher disease 156
Idiopathic brain calcification in a patient with hereditary hemochromatosis 155
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 154
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 149
Iron and the liver 148
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 146
Genetic iron overload disorders 145
Iron Metabolism in the Disorders of Heme Biosynthesis 142
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 141
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 138
Fegato, pancreas e vie biliari. 135
Post COVID-19 irritable bowel syndrome 130
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 130
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 129
Iron in Porphyrias: Friend or Foe? 128
Haemochromatosis 127
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 125
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 124
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 120
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 119
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 117
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 115
EASL Clinical Practice Guidelines on haemochromatosis 115
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 105
Iron overload disorders 102
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 101
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 94
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 86
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 82
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 76
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 75
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 73
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 61
Haematological parameters in erythropoietic protoporphyria: A multi-national study 58
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 51
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 50
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 2
Totale 17.021
Categoria #
all - tutte 71.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.251 0 0 0 0 0 200 193 303 77 160 137 181
2021/20221.503 90 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/20263.654 560 426 816 817 883 152 0 0 0 0 0 0
Totale 17.021